000 01329 a2200361 4500
005 20250517122413.0
264 0 _c20170118
008 201701s 0 0 eng d
022 _a1536-0229
024 7 _a10.1097/RLU.0000000000001424
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGofrit, Ofer Nathan
245 0 0 _aPET/CT With 68Ga-DOTA-TATE for Diagnosis of Neuroendocrine: Differentiation in Patients With Castrate-Resistant Prostate Cancer.
_h[electronic resource]
260 _bClinical nuclear medicine
_cJan 2017
300 _a1-6 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeuroendocrine Tumors
_xdiagnostic imaging
650 0 4 _aOrganometallic Compounds
650 0 4 _aPositron Emission Tomography Computed Tomography
650 0 4 _aProstatic Neoplasms, Castration-Resistant
_xdiagnostic imaging
650 0 4 _aRadiopharmaceuticals
700 1 _aFrank, Stephen
700 1 _aMeirovitz, Amichay
700 1 _aNechushtan, Hovav
700 1 _aOrevi, Marina
773 0 _tClinical nuclear medicine
_gvol. 42
_gno. 1
_gp. 1-6
856 4 0 _uhttps://doi.org/10.1097/RLU.0000000000001424
_zAvailable from publisher's website
999 _c26545240
_d26545240